American Heart Journal
Volume 159, Issue 3 , Pages 370-376 , March 2010

In-hospital management of patients with atrial flutter

  • Nancy M. Allen LaPointe, PharmD

      Affiliations

    • Duke Clinical Research Institute, Duke University Medical Center, Durham, NC
    • Corresponding Author InformationReprint requests: Nancy M. Allen LaPointe, PharmD, Duke Clinical Research Institute, PO Box 17969, Durham, NC 27715.
    • ,
  • Jie-Lena Sun, MS

      Affiliations

    • Duke Clinical Research Institute, Duke University Medical Center, Durham, NC
    • ,
  • Sigal Kaplan, PhD, BPharm

      Affiliations

    • US Food and Drug Administration, Center of Drug Evaluation and Research, Office of Surveillance and Epidemiology, Silver Spring, MD

Received 2 December 2009 ,Accepted 18 December 2009.

References 

  1. Waldo AL, Feld GK. Inter-relationships of atrial fibrillation and atrial flutter. J Am Coll Cardiol. 2008;51:779–786
  2. Granada J, Uribe W, Chyou PH, et al. Incidence and predictors of atrial flutter in the general population. J Am Coll Cardiol. 2000;36:2242–2246
  3. Wellens HJ. Contemporary management of atrial flutter. Circulation. 2002;106:649–652
  4. Saxon LA, Kalman JM, Olgin JE, et al. Results of radiofrequency catheter ablation for atrial flutter. Am J Cardiol. 1996;77:1014–1016
  5. Allen LaPointe NM, Sun JL, Kaplan S, et al. Rhythm versus rate control in the contemporary management of atrial fibrillation in-hospital. Am J Cardiol. 2008;101:1134–1141
  6. Fuster V, Ryden LE, Asinger RW, et al. ACC/AHA/ESC guidelines for the management of patients with atrial fibrillation: executive summary. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines and Policy Conferences (Committee to Develop Guidelines for the Management of Patients with Atrial Fibrillation): developed in collaboration with the North American Society of Pacing and Electrophysiology. J Am Coll Cardiol. 2001;38:1231–1266
  7. Fuster V, Rydén LE, Cannom DS, et al. ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation—executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation). J Am Coll Cardiol. 2006;48:854–906
  8. Blomström-Lundqvist C, Scheinman MM, Aliot EM, et al. ACC/AHA/ESC guidelines for the management of patients with supraventricular arrhythmias—executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines, and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Develop Guidelines for the Management of Patients With Supraventricular Arrhythmias.). J Am Coll Cardiol. 2003;42:1493–1531
  9. Da Costa A, Thévenin J, Roche F, et al. Results from the Loire-Ardèche-Drôme-Isère-Puy-de-Dôme (LADIP) trial on atrial flutter: a multicenter, prospective, randomized study comparing amiodarone and radiofrequency ablation after the first episode of symptomatic atrial flutter. Circulation. 2006;114:1676–1681
  10. Perez FJ, Shubert CM, Parvez B, et al. Long-term outcomes after catheter ablation of cavo-tricuspid isthmus dependent atrial flutter: a meta-analysis. Circ Arrhythmia Electrophysiol. 2009;2:393–401
  11. Liang K, Zeger S. Longitudinal data analysis using generalized linear models. Biometrika. 1986;73:13–22
  12. Wyse DG, Waldo AL, DiMarco JP, et al. A comparison of rate control and rhythm control in patients with atrial fibrillation. N Engl J Med. 2002;347:1825–1833
  13. Riva S, Tondo C, Carbucicchio C, et al. Incidence and clinical significance of transformation of atrial flutter in patients undergoing long-term antiarrhythmic drug treatment. Europace. 1999;1:242–247
  14. Van Gelder IC, Tuinenburg AE, Schoonderwoerd BS, et al. Pharmacologic versus direct-current electrical cardioversion of atrial flutter and fibrillation. Am J Cardiol. 1999;84:147R–151R
  15. Scholten MF, Thornton AS, Mekel JM, et al. Anticoagulation in atrial fibrillation and flutter. Europace. 2005;7:492–499
  16. Seidl K, Hauer B, Schwick NG, et al. Risk of thromboembolic events in patients with atrial flutter. Am J Cardiol. 1998;82:580–583
  17. Corrardo G, Sgalambro A, Mantero A, et al. Thromboembolic risk in atrial flutter. Eur Heart J. 2001;22:1042–1051

PII: S0002-8703(09)00967-3

doi: 10.1016/j.ahj.2009.12.013

American Heart Journal
Volume 159, Issue 3 , Pages 370-376 , March 2010

Article Tools

* Image Usage & Resolution